Name: Immunomodulatory Biomaterials for Cell Therapy and Tissue Engineering: Recent Advancements (en Inglés)
Price: 90310.00 CLP
Availability: InStock
Author: Mukherjee, Sudip ; Kim, Boram ; Hernandez, Andrea
ISBN: 9783031508431

portada Immunomodulatory Biomaterials for Cell Therapy and Tissue Engineering: Recent Advancements (en Inglés)

Formato

Libro Físico

Autor

Editorial

Idioma

Inglés

N° páginas

Encuadernación

Tapa Dura

Dimensiones

16.8 x 24.0 x 1.0 cm

Peso

0.32 kg.

ISBN13

9783031508431

N° edición

Categorías

Ingeniería biomédica
Química
Biotecnología
Ciencia de materiales

Immunomodulatory Biomaterials for Cell Therapy and Tissue Engineering: Recent Advancements (en Inglés)

Sudip Mukherjee (Autor) · Boram Kim (Autor) · Andrea Hernandez (Autor) · Springer · Tapa Dura

Libro Nuevo

$ 90.310

$ 150.520

Ahorras: $ 60.210

40% descuento

Envío normal

Origen: Reino Unido (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Viernes 21 de Junio y el Lunes 01 de Julio.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Immunomodulatory Biomaterials for Cell Therapy and Tissue Engineering: Recent Advancements (en Inglés)"

This book presents the recent developments in immunomodulatory biomaterials for cell-based therapies in various diseases, including diabetes, cancer, cardiovascular disease, and bone regeneration. The authors first cover the fundamentals of conventional immunology and immunomodulation, before focusing on the history, advantages, and challenges of cell therapies. Biological cell therapy has gained immense attention for various diseases due to unique advantages it has over chemical drugs regarding cost, ease of production, toxicity, and therapeutic efficacy. However, these cell-based therapies need an inert delivery system that can locally deliver cells and minimally elicit foreign body response. The book discusses the foreign body response to the immunomodulatory biomaterials as well as the current and future strategies for potential mitigation of considerable immune responses toward immunomodulatory biomaterials and devices.